Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.71 EUR | -4.74% |
|
-14.50% | +56.88% |
05-16 | GeNeuro SA Announces Last Patient Last Visit in Its Post-Covid Trial and Confirms Top-Line Results by End of June 2024 | CI |
03-20 | Geneuro SA Announces Appointments of Board of Directors | CI |
- Stock Market
- Equities
- GNRO Stock
- News GeNeuro SA
- Other languages